These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clozapine treatment in Australia: a review of haematological monitoring. Copolov DL, Bell WR, Benson WJ, Keks NA, Strazzeri DC, Johnson GF. Med J Aust; 1998 May 18; 168(10):495-7. PubMed ID: 9631674 [Abstract] [Full Text] [Related]
4. Time for a change to clozapine haematological monitoring. Cheng A, Buten S, Large M. Australas Psychiatry; 2024 Aug 18; 32(4):342-345. PubMed ID: 38820548 [Abstract] [Full Text] [Related]
5. Re: Late-onset neutropenia with clozapine. Duggal HS, Singh I. Can J Psychiatry; 2006 Feb 18; 51(2):125; author reply 125-6. PubMed ID: 16989111 [No Abstract] [Full Text] [Related]
8. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Atkin K, Kendall F, Gould D, Freeman H, Liberman J, O'Sullivan D. Br J Psychiatry; 1996 Oct 18; 169(4):483-8. PubMed ID: 8894200 [Abstract] [Full Text] [Related]
14. Genetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric population. van der Weide K, Loovers H, Pondman K, Bogers J, van der Straaten T, Langemeijer E, Cohen D, Commandeur J, van der Weide J. Pharmacogenomics J; 2017 Oct 18; 17(5):471-478. PubMed ID: 27168101 [Abstract] [Full Text] [Related]